APA (7th ed.) Citation

Hall, K., Saneto, R., Randle, S., Wainwright, M. S., Berry, P., Leary, S., . . . Hauptman, J. S. (2025). Phase 1 study of ABI‐009 (nab‐rapamycin) for surgically refractory epilepsy (RaSuRE). Epilepsia (Series 4), 66(11), 4246. https://doi.org/10.1111/epi.18555

Chicago Style (17th ed.) Citation

Hall, Koko, et al. "Phase 1 Study of ABI‐009 (nab‐rapamycin) for Surgically Refractory Epilepsy (RaSuRE)." Epilepsia (Series 4) 66, no. 11 (2025): 4246. https://doi.org/10.1111/epi.18555.

MLA (9th ed.) Citation

Hall, Koko, et al. "Phase 1 Study of ABI‐009 (nab‐rapamycin) for Surgically Refractory Epilepsy (RaSuRE)." Epilepsia (Series 4), vol. 66, no. 11, 2025, p. 4246, https://doi.org/10.1111/epi.18555.